2159 related articles for article (PubMed ID: 30505306)
61. Tissue-resident memory CD8
Wang T; Shen Y; Luyten S; Yang Y; Jiang X
Pharmacol Res; 2020 Sep; 159():104876. PubMed ID: 32422340
[TBL] [Abstract][Full Text] [Related]
62. Trigger-happy resident memory CD4
Oja AE; Piet B; Helbig C; Stark R; van der Zwan D; Blaauwgeers H; Remmerswaal EBM; Amsen D; Jonkers RE; Moerland PD; Nolte MA; van Lier RAW; Hombrink P
Mucosal Immunol; 2018 May; 11(3):654-667. PubMed ID: 29139478
[TBL] [Abstract][Full Text] [Related]
63. Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8
Park J; Kwon M; Kim KH; Kim TS; Hong SH; Kim CG; Kang SG; Moon JH; Kim EH; Park SH; Chang JH; Shin EC
Clin Cancer Res; 2019 Apr; 25(8):2549-2559. PubMed ID: 30659023
[TBL] [Abstract][Full Text] [Related]
64. TOX-expressing terminally exhausted tumor-infiltrating CD8
Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
[TBL] [Abstract][Full Text] [Related]
65. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8
Ge Z; Zhou G; Campos Carrascosa L; Gausvik E; Boor PPC; Noordam L; Doukas M; Polak WG; Terkivatan T; Pan Q; Takkenberg RB; Verheij J; Erdmann JI; IJzermans JNM; Peppelenbosch MP; Kraan J; Kwekkeboom J; Sprengers D
Cell Mol Gastroenterol Hepatol; 2021; 12(2):443-464. PubMed ID: 33781741
[TBL] [Abstract][Full Text] [Related]
66. Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.
Bösmüller HC; Wagner P; Peper JK; Schuster H; Pham DL; Greif K; Beschorner C; Rammensee HG; Stevanović S; Fend F; Staebler A
Int J Gynecol Cancer; 2016 May; 26(4):671-9. PubMed ID: 26905331
[TBL] [Abstract][Full Text] [Related]
67. Cancer stem-like cells evade CD8
Corgnac S; Damei I; Gros G; Caidi A; Terry S; Chouaib S; Deloger M; Mami-Chouaib F
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35418483
[TBL] [Abstract][Full Text] [Related]
68. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4
Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI
Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422
[TBL] [Abstract][Full Text] [Related]
69. T
Reilly EC; Lambert Emo K; Buckley PM; Reilly NS; Smith I; Chaves FA; Yang H; Oakes PW; Topham DJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12306-12314. PubMed ID: 32439709
[TBL] [Abstract][Full Text] [Related]
70. Detection of HIV-1-specific gastrointestinal tissue resident CD8
Kiniry BE; Li S; Ganesh A; Hunt PW; Somsouk M; Skinner PJ; Deeks SG; Shacklett BL
Mucosal Immunol; 2018 May; 11(3):909-920. PubMed ID: 29139476
[TBL] [Abstract][Full Text] [Related]
71. CD103 and Intratumoral Immune Response in Breast Cancer.
Wang ZQ; Milne K; Derocher H; Webb JR; Nelson BH; Watson PH
Clin Cancer Res; 2016 Dec; 22(24):6290-6297. PubMed ID: 27267849
[TBL] [Abstract][Full Text] [Related]
72. Resident Memory-Like Tumor-Infiltrating Lymphocytes (TIL
Smazynski J; Webb JR
Front Immunol; 2018; 9():1741. PubMed ID: 30093907
[TBL] [Abstract][Full Text] [Related]
73. PD-1 blockade-unresponsive human tumor-infiltrating CD8
Kim KH; Kim HK; Kim HD; Kim CG; Lee H; Han JW; Choi SJ; Jeong S; Jeon M; Kim H; Koh J; Ku BM; Park SH; Ahn MJ; Shin EC
Cell Mol Immunol; 2021 Feb; 18(2):385-397. PubMed ID: 32332901
[TBL] [Abstract][Full Text] [Related]
74. T cell interaction with activated endothelial cells primes for tissue-residency.
Wienke J; Veldkamp SR; Struijf EM; Yousef Yengej FA; van der Wal MM; van Royen-Kerkhof A; van Wijk F
Front Immunol; 2022; 13():827786. PubMed ID: 36172363
[TBL] [Abstract][Full Text] [Related]
75. Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study.
Rashed HE; Abdelrahman AE; Abdelgawad M; Balata S; Shabrawy ME
Turk Patoloji Derg; 2017; 1(1):211-222. PubMed ID: 28832075
[TBL] [Abstract][Full Text] [Related]
76. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
77. PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating Lymphocytes.
He Y; Rozeboom L; Rivard CJ; Ellison K; Dziadziuszko R; Yu H; Zhou C; Hirsch FR
Med Sci Monit; 2017 Mar; 23():1208-1216. PubMed ID: 28275222
[TBL] [Abstract][Full Text] [Related]
78. Functions of human liver CD69
Kim JH; Han JW; Choi YJ; Rha MS; Koh JY; Kim KH; Kim CG; Lee YJ; Kim AR; Park J; Kim HK; Min BS; Seo SI; Kang M; Park HJ; Han DH; Kim SI; Kim MS; Lee JG; Lee DH; Kim W; Park JY; Park SH; Joo DJ; Shin EC
J Hepatol; 2020 Jun; 72(6):1170-1181. PubMed ID: 31987989
[TBL] [Abstract][Full Text] [Related]
79. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.
Steele KE; Tan TH; Korn R; Dacosta K; Brown C; Kuziora M; Zimmermann J; Laffin B; Widmaier M; Rognoni L; Cardenes R; Schneider K; Boutrin A; Martin P; Zha J; Wiestler T
J Immunother Cancer; 2018 Mar; 6(1):20. PubMed ID: 29510739
[TBL] [Abstract][Full Text] [Related]
80. Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients.
Giatromanolaki A; Anestopoulos I; Panayiotidis MI; Mitrakas A; Pappa A; Koukourakis MI
Anticancer Res; 2021 Aug; 41(8):3989-3995. PubMed ID: 34281863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
